HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Asahi Ito Selected Research

Genomic Instability

3/2022Acute Promyelocytic Leukemia in a Patient With Chronic Continuous Type of Crohn's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Asahi Ito Research Topics

Disease

21Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2023 - 02/2009
19Neoplasms (Cancer)
01/2022 - 11/2008
13Multiple Myeloma
06/2020 - 11/2008
9Lymphoma (Lymphomas)
06/2023 - 06/2010
4Hepatitis
09/2022 - 06/2010
3Leukemia
01/2023 - 03/2012
3Hematologic Neoplasms (Hematological Malignancy)
09/2022 - 09/2016
3Infections
09/2022 - 04/2015
3Disease Progression
01/2022 - 11/2020
2Inflammation (Inflammations)
02/2023 - 03/2022
2Acute Promyelocytic Leukemia
01/2023 - 12/2022
2Paraproteinemias (Monoclonal Gammopathy)
01/2023 - 01/2018
2Large Granular Lymphocytic Leukemia
01/2023 - 12/2018
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 05/2021
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2023
1Pain (Aches)
02/2023
1Thrombocytopenia (Thrombopenia)
02/2023
1Pericarditis
02/2023
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2023
1Genomic Instability
03/2022
1Crohn Disease (Crohn's Disease)
03/2022
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2020
1Cardiotoxicity
11/2020
1Back Pain (Backache)
06/2020
1Lymphopenia (Lymphocytopenia)
01/2020
1Communicable Diseases (Infectious Diseases)
08/2019
1Chromosome Aberrations (Chromosome Abnormalities)
08/2019
1Fever (Fevers)
08/2019
1Fungemia
08/2019
1Blast Crisis (Blast Phase)
07/2019
1Pleural Effusion (Pleural Effusions)
07/2019
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2019
1Primary Myelofibrosis (Myelosclerosis)
07/2019
1Hemorrhagic Cystitis
01/2019
1Erythema Multiforme
01/2019
1Extranodal NK-T-Cell Lymphoma
12/2018

Drug/Important Bio-Agent (IBA)

11mogamulizumabIBA
12/2022 - 05/2013
8Monoclonal AntibodiesIBA
01/2020 - 08/2009
6Bortezomib (Velcade)FDA Link
06/2020 - 11/2008
6Dexamethasone (Maxidex)FDA LinkGeneric
04/2020 - 03/2016
6Proteins (Proteins, Gene)FDA Link
12/2018 - 07/2009
5Rituximab (Mabthera)FDA Link
11/2020 - 07/2009
4Immunoglobulin G (IgG)IBA
06/2023 - 01/2018
4DNA (Deoxyribonucleic Acid)IBA
09/2022 - 06/2010
4Tryptophan (L-Tryptophan)FDA Link
12/2020 - 06/2015
4Lenalidomide (CC 5013)FDA Link
04/2020 - 04/2013
3Messenger RNA (mRNA)IBA
06/2023 - 03/2012
3Proteasome InhibitorsIBA
02/2018 - 02/2009
2mRNA VaccinesIBA
06/2023 - 01/2023
2Biomarkers (Surrogate Marker)IBA
10/2022 - 09/2022
2AntigensIBA
09/2022 - 03/2012
2Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2022 - 06/2010
2LigandsIBA
01/2022 - 07/2009
2Prednisolone (Predate)FDA LinkGeneric
11/2020 - 06/2020
2Complement System Proteins (Complement)IBA
01/2019 - 12/2010
2Cyclin-Dependent Kinase 9IBA
12/2018 - 01/2017
2atuveciclibIBA
12/2018 - 01/2017
2Bevacizumab (Avastin)FDA Link
03/2014 - 01/2012
1SARS-CoV-2 spike proteinIBA
06/2023
1Inosine Triphosphate (ITP)IBA
02/2023
1romiplostimFDA Link
02/2023
1eltrombopagFDA Link
02/2023
1Transferrin Receptors (Transferrin Receptor)IBA
01/2023
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2023
1Transferrin (beta 2 Transferrin)IBA
01/2023
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
12/2022
1A-factor (Streptomyces)IBA
03/2022
1Azathioprine (Imuran)FDA LinkGeneric
03/2022
1Pyridinolcarbamate (P23)IBA
05/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2020
1AnthracyclinesIBA
11/2020
1Vincristine (Oncovin)FDA LinkGeneric
11/2020
1Melphalan (Alkeran)FDA LinkGeneric
06/2020
1NucleotidesIBA
06/2020
1entecavirFDA Link
06/2020
1daratumumabIBA
06/2020
1Voriconazole (Vfend)FDA LinkGeneric
08/2019
1ponatinibIBA
07/2019
1Dasatinib (BMS 354825)FDA Link
07/2019
1Signaling Lymphocytic Activation Molecule FamilyIBA
07/2019
1AntibodiesIBA
07/2019
1Surface Antigens (Surface Antigen)IBA
07/2019
1Immunoglobulin M (IgM)IBA
01/2019
1AutoantibodiesIBA
01/2019
1RNA Polymerase II (RNA Polymerase B)IBA
12/2018
1Serine (L-Serine)FDA Link
12/2018
1pomalidomideIBA
06/2018
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
06/2018
1afuresertibIBA
06/2018
1ChymotrypsinFDA Link
02/2018
1Proteasome Endopeptidase Complex (Proteasome)IBA
02/2018

Therapy/Procedure

12Therapeutics
01/2023 - 01/2006
12Drug Therapy (Chemotherapy)
09/2022 - 06/2010
4Immunotherapy
11/2015 - 03/2012
3Hematopoietic Stem Cell Transplantation
07/2019 - 04/2013
2Stem Cell Transplantation
01/2018 - 06/2010
1VAP-cyclo protocol
11/2020
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2019
1Drug Tapering
01/2019